the scientific literature reporting on DA-HAI rates by means of using standardized definitions is scarce. [10] [11] [12] [13] [14] [15] [16] [17] [18] The International Nosocomial Infection Control Consortium (INICC) was founded in 1998, after selected hospitals from Latin America were invited to participate in the project to measure DA-HAI using standardized definitions and methodology. 19 Shortly afterwards, other hospitals located in different parts of the world joined the Consortium. At present, the INICC comprises a worldwide network with hospitals in 40 countries of Latin America, Asia, Africa, and Europe. [10] [11] [12] [13] [14] [15] [16] [17] [18] On a monthly basis, healthcare facilities send data to the INICC, which are then entered into an international database. Hospital members of the INICC provide general medical and surgical inpatient services to adults and children hospitalized in the ICUs.
In China, published data on DA-HAI rates are not available in the English language. The findings of the present study in Shanghai form an integral part of the INICC and reflect the outcome surveillance data that were systematically collected.
Methods

Setting
This study was carried out in 398 ICUs of 70 hospitals, from September 2004 to December 2009. The hospitals have an infection control team composed of physicians and ICPs with experience in infection control. The infection control teams include at least one full time physician and several infection control nurses. The nurses involved are all professionals and work full-time in infection control. They are responsible for collecting information from patients, and once a DAI is suspected, they report it to the physician for an immediate diagnosis. The ICPs listed in Table 1 work full time, but at each hospital there are also several part-time nurses who also collaborate in the diagnosis of DAI. The ICPs in Shanghai are all trained by the Municipal Infection Control Center. This center provides training courses twice a year, and each course lasts approximately 3-5 days. The performances of the ICPs in these 70 hospitals are assessed by the Municipal Infection Control Center each year.
The clinical microbiology laboratory provides in vitro susceptibility testing of clinical isolates using standardized methods. All the hospitals analyzed the samples in their own microbiology laboratories. This analysis included routine culture of the specimens and conventional phenotypic identification using automated machines (BD Phoenix or VITEK 2) or API strips. The sensitivity of the microorganisms was defined by the automated machines (BD Phoenix or VITEK 2) or by drug sensitive slips method.
The nurse-to-patient ratio is 2-2.5:1 in the participating ICUs, as required by the Quality Control Center of Critical Medicine and Infection Control. The institutional review boards of the hospitals approved the study protocol. Patient confidentiality was protected by codifying the recorded information, making it only identifiable to the infection control team.
Fifty-one percent of the participating hospitals are categorized as 'complexity level 2' (which means that they are hospitals in medium-size cities, counties, or districts, with more than 100 beds, but fewer than 500), and 49% as 'complexity level 3' (general or comprehensive hospital at the national, provincial, or city level, with more than 500 beds) ( Table 1) 
Surveillance
On a daily basis, data were collected by the infection control teams prospectively from all the patients admitted to the ICUs by means of specifically designed forc the DA-HAI definitions provided by the CDC-NNIS and CDC-NHSN. 6, 7 ICUs were stratified into types according to the patient population: adult ICU or pediatric ICU.
The identity of all INICC Shanghai hospitals is confidential, in accordance with the INICC Charter.
Device-days consisted of the total number of central line (CL)-days, urinary catheter (UC)-days, or mechanical ventilator (MV)-days.
DA-HAI rate calculations
Outcomes measured during the surveillance period included the incidence density rate of central line-associated blood stream infection (CLABSI; number of CLABSI divided by 1000 CL-days and multiplied by 1000); catheter-associated urinary tract infection (CAUTI; number of CAUTI divided by 1000 UC-days and multiplied by 1000); and ventilator-associated pneumonia (VAP; number of VAP divided by 1000 MV-days and multiplied by 1000). DU ratios were calculated by dividing the total number of device-days by the total number of bed-days. 20 
Statistical analysis
EpiInfo version 6.04b (CDC, Atlanta, GA, USA) and SPSS 16.0 (SPSS Inc. an IBM company, Chicago, IL, USA) were used to perform the data analysis.
Chi-square analyses for dichotomous variables and the t-test for continuous variables were used to analyze baseline differences among rates. Relative risk (RR) ratios, 95% confidence intervals (CIs), and p-values were determined for all outcomes. The level of significance was set at p < 0.05.
Results
During the 5 years and 4 months of the study, 391 527 patients hospitalized in an ICU for an aggregate of 3 245 244 days acquired 20 866 DA-HAIs, an overall rate of 5.3% (95% CI 5.3-5.4) of DA-HAIs and 6.4 (95% CI 6.3-6.5) DA-HAIs per 1000 ICU-days. The characteristics of the 398 ICUs at INICC Shanghai hospitals that contributed data to this report are shown in Table 1 .
The overall CLABSI rate was 3.1 (95% CI 3.0-3.2). The highest CLABSI rate was found in the medical ICUs: 4.3 per 1000 CL-days (95% , and the lowest rates in the burn ICUs and trauma ICUs (0.0 and 1.1 per 1000 CL-days, respectively). The difference between the medical and trauma ICUs was significant (RR 0.86, , p = 0.0004). The DU ratio of CL was higher in trauma ICUs at 0.41, than in the medical ICUs at 0.18 (p < 0.001) ( Tables 2 and 3 ).
The VAP rate was in all the ICUs combined. The highest VAP rate was found in the trauma ICUs: 39.2 per 1000 MV-days (95% , and the lowest in the burn ICUs: 7.5 per 1000 MV-days (95% CI 0. 1-40.9) . However, the difference in the VAP rates between these ICUs was not significant (p = 0.06). The highest MV DU ratio was found in the trauma ICUs: 0.32 (Tables 4 and 5 ). The overall CAUTI rate was 6.4 (95% CI 6.3-6.6). The highest CAUTI rate was found in the coronary care ICUs: 12.8 per 1000 UCdays (95% CI 12.0-13.6), and the lowest rates in the burn and cardiothoracic ICUs: 0.0 and 1.4 per 1000 UC-days, respectively. The difference between coronary care and cardiothoracic ICUs was significant regarding the CAUTI rate (p < 0.001) and the UC DU ratio (0.12 in coronary care ICUs compared to 0.35 in cardiothoracic ICUs, p < 0.001). The highest UC DU ratio was found in the burn ICUs: 0.68. (Tables 6 and 7) . Table 8 shows the DA-HAI rates stratified by hospital size. The highest CLABSI rate was found in the larger-size hospitals, whose rate (3.4 per 1000 CL-days) was significantly higher than that in the medium-size hospitals (2.2 per 1000 CL-days) (RR 1.57, 95% CI 1.43-1.73, p < 0.001). The CAUTI rate, however, was higher in the smaller-size hospitals (8.0 per 1000 UC-days) than in the larger ones (5.6 per 1000 UC-days) (RR 1.44, 95% CI 1.34-1.55, p < 0.01). VAP rates were similar for all hospital sizes. Table 9 shows the evolution of DA-HAI rates by year. It is noteworthy that the VAP rate improved over the years, decreasing from 26.0 (24.0-28.2) in 2004 to 15.8 (15.1-16.5 ) in 2009; this reduction of 39% was significant (RR 0.61, 95% CI 0.55-0.66, p < 0.01). The CAUTI rate also declined, from 7.4 to 4.9 (RR 0.67, 95% CI 0.59-0.75, p < 0.001). However, CLABSI rates remained stable. We also noticed that the overall VAP rate was higher in the public hospitals as compared with the academic hospitals (29.5 vs. 17.4 , p < 0.01), and was also higher in the medium-complexity hospitals as compared with the high-complexity ones (25.0 vs. 19 .0, p < 0.01). Table 10 compares overall rates of CLABSI, CAUTI, and VAP in the INICC Shanghai ICUs and CDC NHSN ICUs. (1) Although NHSN rates were lower in the medical and surgical ICUs for all infection types, in the pediatric ICUs, the CLABSI rates were similar and the CAUTI rate was higher in the NHSN than in this study (4.2 compared to 2.6 per 1000 UC-days). Table 11 shows the distribution of the 9043 isolated pathogens involved in device-associated infections. Acinetobacter baumannii was the most common microorganism (19.1%), followed by Pseudomonas aeruginosa. This indicates that Gram-negative bacteria were the most frequent overall. Staphylococcus aureus was the most common organism in CLABSI patients and Candida spp in CAUTI patients.
Discussion
It has been 30 years since the effectiveness of implementing an integrated infection control program focused on HAI surveillance was demonstrated. As reported in the many studies conducted in the USA, the incidence of HAI may be reduced by as much as 30%, enabling a feasible associated reduction in healthcare costs. 21 For more than 30 years, the CDC's NNIS/NHSN network has provided benchmark US ICU data on DAIs and antibiotic resistance, which have proven invaluable for researchers, and have served as an inspiration to the INICC program. 1, 8, [22] [23] [24] [25] [26] [27] Initially, INICC surveillance was concentrated on DAI surveillance in the ICU, a healthcare setting with the highest HAI rates, in which patient safety is most seriously threatened, due to their critical condition and exposure to invasive devices. 28 In our study the most frequently isolated microorganism was A. baumannii, followed by P. aeruginosa. We had positive sputum culture results from 74% of all study patients with VAP, 25% of which were positive for Acinetobacter sp. In a previous study conducted in Hubei, China, P. aeruginosa was the most common microorganism, followed by Escherichia coli and A. baumannii. 29 In a different study also carried out in China in 2002,
A. baumannii was the most common microorganism.
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The rate of device use in Shanghai ICUs is lower than that reported in US ICUs by the NNIS/NHSN system. 1, 25, 27 However, DA-HAI rates identified in Shanghai ICUs were higher than the published US rates (Table 9) . 1, 27 Although the difference in CLABSI and CAUTI is not considered significant, the VAP rate in Shanghai is particularly high in the ICUs in this study in comparison to the NNIS/NHSN rates. In a recent KISS (Krankenhaus Infektions Surveillance System) study in Germany, the VAP rate was 5.44, which is higher than that reported in the NHSN, but again still much lower than the rate found in our study.
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In the surgical ICUs of the Shanghai INICC network, the CLABSI rate was lower than the INICC pooled rates, the CAUTI rate was similar, and the VAP rate was higher. In the medical ICUs of the Shanghai INICC network, the CLABSI rate was lower than the INICC pooled rate, but the CAUTI rate and the VAP rate were higher. In the pediatric ICUs of the Shanghai INICC network, the CLABSI and CAUTI rates were lower than the INICC pooled rates and the VAP rate was higher. 13 These higher DA-HAI rates may reflect the typical ICU situation in limited-resource countries as a whole. [32] [33] [34] Among the primary plausible causes, it should be mentioned that, in the majority of limited-resource countries, adherence to infection control programs is irregular. Although few patients receive non-invasive ventilation in the ICU, device utilization rates are low in China. The severity of illness in patients is not frequently evaluated, so patients are not discharged from the ICU in a timely manner, which could partly explain the low utilization rate. To reduce the risk of infection in hospitalized patients, DA-HAI surveillance is of primary importance, because it effectively describes and addresses the importance and characteristics of the threatening situation created by DA-HAIs. This must be followed by the implementation of practices aimed at DA-HAI prevention and control. Additionally, participation in the INICC has played a fundamental role, not only in increasing the awareness of DAI risks in the INICC ICUs, but also in providing an exemplary basis for the institution of infection control practices. In many INICC ICUs, for example, the high incidence of DA-HAI has been reduced by carrying out targeted performance feedback programs for hand hygiene, and centralline, ventilator, and urinary catheter care. 15, [35] [36] [37] [38] [39] [40] [41] Finally, to effectively control antibiotic resistance, the administration of anti-infectives must be restricted.
To compare a hospital's DA-HAI rates and DU ratios with the rates identified in this report, it is required that the hospital concerned start collecting their data by applying the methods and methodology described by the CDC NHSN and INICC, and then calculate infection rates and DU ratios for the device-associated module.
The particular and primary application of these data is to serve as a guide for the implementation of prevention strategies and other quality improvement efforts locally, in order to help reduce DA-HAI rates to the minimum possible level.
To conclude, the data reported in this study strengthen the fact that DA-HAIs, particularly in ICU patients from low-income countries, must be regarded as a serious and often concealed threat to patient safety, as compared to the developed world. It is the primary objective of the INICC to foster infection control practices by facilitating elemental, feasible, and inexpensive tools and resources to tackle this problem effectively and systematically, leading to greater and stricter adherence to infection control programs and guidelines, and to the correlated reduction in DA-HAI and their adverse consequences in the ICUs participating in the INICC, as well as at any other healthcare facility in the developing world.
